A randomised phase II study of pegylated arginine deiminase (ADI-PEG 20) in Asian advanced hepatocellular carcinoma patients.
Yang TS, Lu SN, Chao Y, Sheen IS, Lin CC, Wang TE, Chen SC, Wang JH, Liao LY, Thomson JA, Wang-Peng J, Chen PJ, Chen LT.
Yang TS, et al. Among authors: chen sc, chen lt, chen pj.
Br J Cancer. 2010 Sep 28;103(7):954-60. doi: 10.1038/sj.bjc.6605856. Epub 2010 Aug 31.
Br J Cancer. 2010.
PMID: 20808309
Free PMC article.
Clinical Trial.